Dorothy Clarke

Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT.

Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ.

Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

BBK Ltd. provides finance, strategy, operations and general managements consultancy services. It provides finance, strategy, operations and general management consultancy services that monitor the growth, profits and stability of its clients. The company's clients include corporations, mid-sized companies, financial institutions, law firms and private equity firms. BBK was founded by B.N. Bahadur in 1977 and is headquartered in Southfield, MI.

Berenson & Co, Inc. is a merchant bank that was founded in 1990. The private company is based in New York, NY and has subsidiaries in the United States. The company has two principal lines of business which are investment banking and private equity investing. The company was founded by Robb Eric Turner and Jeffrey L. Berenson. Jeffrey L. Berenson has been the CEO since incorporation.

VMR Electronics LLC designs and manufactures cable assembly products. The company was founded by Mark and Vanessa Kelly in 2001 and is headquartered in Binghamton, NY.

Upstate New York Power Producers, Inc. owns and operates coal-fired power plants. The company is headquartered in Lansing, NY.

ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.

Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel.

SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ.

Sollis Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company developing novel non-steroid and non-opioid analgesics. The company was founded by Gregory Fiore and Bryan Jones and is headquartered in Columbus, OH.

Homer City Holdings, LLC is an investment holding private company. The company is based in Dauphin, PA. William A. Wexler has been the CEO of the company since 2017.

Factor Bioscience, Inc. develops regenerative medicine by targeting and repairing the molecular origins of disease. It offers gene editing, cell reprogramming and nucleic-acid delivery. The company was founded by Matt Angel and Christopher Rohde in 2011 and is headquartered in Cambridge, MA.

eGames.com Holdings LLC operates game publishing business. The company is headquartered in Carson City, NV.

Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million.

Part of SSI Strategy LLC, Fiore Healthcare Advisors, Inc. provides pharmacovigilance and clinical research consulting services. The company is based in Boston, MA. The company was founded by Gregory Fiore. Fiore Healthcare Advisors was acquired by SSI Strategy LLC on June 29, 2021.

Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.